Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2026-01-04 @ 7:28 PM
Study NCT ID:
NCT02679456
Status:
COMPLETED
Last Update Posted:
2019-07-12
First Post:
2016-01-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis
Sponsor:
Scynexis, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11
Start Date Type:
None
Primary Completion Date:
2016-08-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-05
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-19
First Submit QC Date:
None
Study First Post Date:
2016-02-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-10
Last Update Post Date:
2019-07-12
Last Update Post Date Type:
ACTUAL